PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23875972-2	2013	The aim of this study was to investigate the underlying molecular mechanism of resistance developed by the mitotic kinesin Eg5 against the potent second-generation ispinesib analogue SB743921 (1), a phase I/II clinical candidate.	SB 743921	183-191	kinesin family member 11	Homo sapiens	123-126	
23899248-2	2013	elucidated the molecular basis of resistance by characterizing the binding interactions between Eg5 and the allosteric inhibitor SB743921.	SB 743921	129-137	kinesin family member 11	Homo sapiens	96-99